Allegra Battistoni
Overview
Explore the profile of Allegra Battistoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferrera A, Fiorentini V, Reale S, Solfanelli G, Tini G, Barbato E, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(5):148.
PMID: 39076747
Chemotherapies have changed the prognosis of patients affected by cancer over the last 20 years, with a significant increase in survival rates. However, they can cause serious adverse effects that...
2.
Fiori E, De Fazio L, Pidone C, Perone F, Tocci G, Battistoni A, et al.
J Hypertens
. 2024 Jul;
42(10):1665-1680.
PMID: 39051476
Asymptomatic hyperuricemia is defined by serum uric acid levels above 6.2 mg/dl in women and 7 mg/dl in men. In the presence of monosodium urate crystal formation and articular inflammation,...
3.
Ferrera A, Battistoni A, Volpe M
Eur Heart J
. 2024 Apr;
45(19):1692-1694.
PMID: 38620068
No abstract available.
4.
Tini G, Tanda S, Toma M, Battistoni A, Musumeci B, Barbato E, et al.
Heart Lung Circ
. 2024 Apr;
33(5):704-709.
PMID: 38609799
Background: It has been postulated that cancer hampers the delivery of guideline-directed medical therapy (GDMT) for heart failure (HF). However, few data are available in this regard. Methods: We performed...
5.
Battistoni A, Volpe M, Morisco C, Piccinocchi G, Piccinocchi R, Fini M, et al.
Cardiovasc Res
. 2024 Mar;
120(6):623-629.
PMID: 38501586
Aims: We evaluated the incidence and relative risk of major post-acute cardiovascular consequences of SARS-CoV-2 infection in a large real-world population from a primary care database in a region at...
6.
Piras L, Zuccanti M, Russo P, Riccio F, Agresti A, Lustri C, et al.
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38473748
In recent years, immune checkpoint inhibitors have significantly changed the field of oncology, emerging as first-line treatment, either alone or in combination with other regimens, for numerous malignancies, improving overall...
7.
Battistoni A, Tocci G, Gallo G, Solfanelli G, Volpe M
High Blood Press Cardiovasc Prev
. 2024 Feb;
31(1):93-96.
PMID: 38416388
Cardiovascular risk factors are prevalent in the Italian population, and cardiovascular diseases remain a leading cause of mortality in the Western world. As the incidence of risk factors and cardiovascular...
8.
Tini G, Arcari L, Mistrulli R, Follesa F, Cianca A, Sclafani M, et al.
Front Cardiovasc Med
. 2024 Jan;
10:1301383.
PMID: 38259302
Takotsubo syndrome (TTS) is characterized by a transient left ventricular systolic dysfunction, burdened by significant acute and long-term mortality and morbidity. The prognosis of TTS, especially in the long-term, is...
9.
Mistrulli R, Ferrera A, Muthukkattil M, Battistoni A, Gallo G, Barbato E, et al.
J Clin Med
. 2024 Jan;
13(2).
PMID: 38256635
Atrial fibrillation (AF) is the most common arrhythmia in patients affected by cardiomyopathies. Reports estimate a prevalence of 27% in patients with hypertrophic cardiomyopathy (HCM) and 40% in patients with...
10.
Mistrulli R, Ferrera A, Muthukkattil M, Volpe M, Barbato E, Battistoni A
J Clin Med
. 2023 Jul;
12(14).
PMID: 37510815
A minority of patients with severe acute respiratory syndrome coronavirus 2 (COVID-19) develop cardiovascular complications, such as acute cardiac lesions with elevated troponins, de novo systolic heart failure, pericardial effusion...